Уважаемые коллеги!
Это старая версия сайта Российского кардиологического общества.
Страница не обновляется. Архив событий и новостей.
Для актуальной информации пройдите на scardio.ru

Fenofibrate cut adverse CV outcomes in women with diabetes by one-third

19.08.20141752
Women with type 2 diabetes and already at risk for heart disease had a 30% reduction in adverse cardiovascular outcomes with the cholesterol-lowering.

Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data

18.08.20141770
We aimed to investigate whether the benefits of blood pressure-lowering drugs are proportional to baseline cardiovascular risk, to establish whether absolute risk could be used to inform treatment decisions for blood pressure-lowering therapy, as is recommended for lipid-lowering therapy.

Studies Explore Effectiveness of Telerobotics in Echocardiography

15.08.20141846
Telerobotics has become an emerging technology in the field of medicine, allowing physicians to conduct life-saving examinations across great distances through a mechanized proxy.

Minister of Health of the Russian Federation V.I.Skvortsova about Russian National Congress of Cardiology

14.08.20142415
On September 24-26, 2014 in Kazan, the Russian National Congress of Cardiology will be held.

Delayed time to conversion for acute AF increased thromboembolic event risk

14.08.20141952
A delay in time to conversion of 12 hours or more from the time of acute atrial fibrillation symptom onset was associated with increased risk for thromboembolic complications, according to new data from the CardioVersion study.

Blood pressure and incidence of twelve cardiovascular diseases

13.08.20141720
The associations of blood pressure with the different manifestations of incident cardiovascular disease in a contemporary population have not been compared.

Increased Mortality Associated With Digoxin in Contemporary Patients With Atrial Fibrillation

12.08.20142027
Despite endorsement of digoxin in clinical practice guidelines, there exist limited data on its safety in atrial fibrillation/flutter (AF).
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.